Cargando…

Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report

BACKGROUND: Lung invasive mucinous adenocarcinoma (LIMA), formerly referred to as mucinous bronchioloalveolar carcinoma, is a rare disease that usually presents as bilateral lung infiltration, is unsuitable for surgery and radiotherapy, and shows poor response to conventional chemotherapy. CASE SUMM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Guo-Chun, Luo, Wen, Zhang, Wei-Shan, Wang, Shu-Hong, Zhao, Jie, Zhao, Hong-Mei, Qiu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850975/ https://www.ncbi.nlm.nih.gov/pubmed/36686363 http://dx.doi.org/10.12998/wjcc.v11.i2.441

Ejemplares similares

Massive Bronchorrhea
por: Kurahara, Yu
Publicado: (2021)

Successful treatment of persistent bronchorrhea by gefitinib in a case with Recurrent Bronchioloalveolar Carcinoma: a case report
por: Takao, Motoshi, et al.
Publicado: (2003)

Bronchial purging: Atypical pulmonary sarcoidosis presenting with bronchorrhea
por: Mahapatra, Shweta, et al.
Publicado: (2018)

Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma
por: Cui, Dongyu, et al.
Publicado: (2023)

Bronchorrhea, a Rare and Debilitating Symptom of Lung Cancer: Case Report and Review of the Treatment
por: Bhagat, Milind, et al.
Publicado: (2022)

Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma
por: Gow, Chien-Hung, et al.
Publicado: (2021)

Invasive mucinous adenocarcinoma of the lung
por: Xu, Lu, et al.
Publicado: (2019)

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China
por: Liu, Yu-Tao, et al.
Publicado: (2015)

Octreotide as a novel agent for the management of bronchorrhea in mechanically ventilated patients: A case series and review of literature
por: Bhandari, Sambhawana, et al.
Publicado: (2023)

Trends of incidence and survival in patients with gastrointestinal mucinous adenocarcinoma
por: Zong, Zhen, et al.
Publicado: (2018)

Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review
por: Tong, Jin, et al.
Publicado: (2023)

Invasive mucinous adenocarcinoma misdiagnosed as pneumonia: A case report
por: Yang, Yuping, et al.
Publicado: (2023)

Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma
por: Yang, Hong, et al.
Publicado: (2021)

Mucinous adenocarcinoma and non-mucinous adenocarcinoma: differing clinicopathological characteristics and computed tomography features in gastric cancer
por: Zhao, Jianxi, et al.
Publicado: (2017)

Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma
por: Yan, Qian, et al.
Publicado: (2019)

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
por: Yuan, Ying, et al.
Publicado: (2012)

Invasive mucinous adenocarcinoma of the lung: Serial CT findings, clinical features, and treatment and survival outcomes
por: Beck, Kyongmin Sarah, et al.
Publicado: (2020)

Gene signature driving invasive mucinous adenocarcinoma of the lung
por: Guo, Minzhe, et al.
Publicado: (2017)

Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax
por: Aoki, Ayako, et al.
Publicado: (2020)

Invasive Mucinous Adenocarcinoma of the Lung Presenting With Multiple Cavities
por: Nakamura, Shunsuke, et al.
Publicado: (2021)

Pulmonary invasive mucinous adenocarcinoma mimicking pulmonary actinomycosis
por: Zhu, Dongyi, et al.
Publicado: (2022)

C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model
por: Tan, Jun, et al.
Publicado: (2015)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

Influence of Autophagy Inhibition on Lung Adenocarcinoma Cell Migration and Invasion Ability, and Efficacy of Gefitinib
por: Liu, Ying, et al.
Publicado: (2021)

Recurrence dynamics after curative surgery in patients with invasive mucinous adenocarcinoma of the lung
por: Yoon, Hyun Jung, et al.
Publicado: (2022)

Epidemiology and survival outcomes of mucinous adenocarcinomas: A SEER population-based study
por: Xie, Guang-Dong, et al.
Publicado: (2018)

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
por: He, Jian, et al.
Publicado: (2023)

Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival
por: Lee, Chung-Ta, et al.
Publicado: (2017)

Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma
por: Zhang, Guochao, et al.
Publicado: (2021)

Hemicolectomy Does Not Provide Survival Benefit for Right-Sided Mucinous Colon Adenocarcinoma
por: Huang, Jia, et al.
Publicado: (2021)

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung
por: Jang, Yoon Jung, et al.
Publicado: (2021)

The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery
por: Vernmark, Karolina, et al.
Publicado: (2023)

Dissimilar survival and clinicopathological characteristics of mucinous adenocarcinoma located in pancreatic head and body/tail
por: Li, Zheng, et al.
Publicado: (2023)

Mucinous Adenocarcinoma of Colon
por: Zamir, Naima, et al.
Publicado: (2010)

Mucinous adenocarcinoma of the appendix
por: Feizi, Iraj, et al.
Publicado: (2015)

Epidemiology of Mucinous Adenocarcinomas
por: Benesch, Matthew G. K., et al.
Publicado: (2020)

Mucinous adenocarcinoma of the abdomen
por: Pan, Jiyong, et al.
Publicado: (2019)

Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
por: Sathyanarayanan, Vishwanath, et al.
Publicado: (2014)

Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma
por: Choi, Hayoung, et al.
Publicado: (2015)

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
por: Satouchi, M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bsmmv3jljv4htugd0glj4qd7sl